Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles
The HIV-1 envelope glycoprotein (Env) is present on the surface of the virion at a very low density compared to most other enveloped viruses. Substitution of various parts of the stalk domain of Env (gp41) with the corresponding elements from other viral glycoproteins has been shown to increase Env...
Main Authors: | Rosamund Chapman, Michiel van Diepen, Shireen Galant, Elizabeth Kruse, Emmanuel Margolin, Phindile Ximba, Tandile Hermanus, Penny Moore, Nicola Douglass, Anna-Lise Williamson, Edward Rybicki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/1/54 |
Similar Items
-
Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
by: Ros Chapman, et al.
Published: (2021-11-01) -
Platforms, advances, and technical challenges in virus-like particles-based vaccines
by: Reeshu Gupta, et al.
Published: (2023-02-01) -
Chimeric VLPs Bearing VP60 from Two Serotypes of <i>Rabbit Haemorrhagic Disease Virus</i> Are Protective against Both Viruses
by: Kevin P. Dalton, et al.
Published: (2021-09-01) -
Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines
by: Rosamund Chapman, et al.
Published: (2023-02-01) -
Chimeric VLPs Based on HIV-1 Gag and a Fusion Rabies Glycoprotein Induce Specific Antibodies against Rabies and Foot-and-Mouth Disease Virus
by: Diego Fontana, et al.
Published: (2021-03-01)